In this issue:
Payment incentive to improve confirmatory testing
Impact of federal funding on referral for mpMRI
Utilisation of MRI in Aotearoa New Zealand
Electroacupuncture for early urinary incontinence post radical prostatectomy
GG1 prostate cancer outcome by biopsy grade and risk group
10-year outcomes of the FLAME trial
Nivolumab and ipilimumab for mCRPC
Homologous recombination repair alterations in mHSPC
Two- vs five-fraction MRI-guided adaptive prostate radiation therapy
AS for low- and intermediate-risk prostate cancer out to 25 years
Please login below to download this issue (PDF)